Results 191 to 200 of about 26,349 (219)
Some of the next articles are maybe not open access.

Cardiac myosin inhibitors for hypertrophic cardiomyopathy: shedding light on their clinical potential

Expert Opinion on Investigational Drugs, 2023
Shiavax J Rao   +5 more
openaire   +2 more sources

Cardiac myosin inhibitors in the treatment of hypertrophic cardiomyopathy (literature review)

Pharmateca, 2023
L.V. Kononenko Kononenko   +2 more
openaire   +1 more source

Cardiac Myosin Inhibitors

Journal of the American College of Cardiology
Torsten B. Rasmussen   +2 more
openaire   +1 more source

Cryo-EM structure of the human cardiac myosin filament

Nature, 2023
Campbell Ks   +2 more
exaly  

Update on Cardiac Myosin Inhibitors and Potential Role in Treating Obstructive Hypertrophic Cardiomyopathy

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2023
Michael J, Litt, Sharlene M, Day
openaire   +2 more sources

Mavacamten stabilizes an autoinhibited state of two-headed cardiac myosin

Proceedings of the National Academy of Sciences of the United States of America, 2018
Osha Roopnarine, , David D Thomas
exaly  

Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers

Proceedings of the National Academy of Sciences of the United States of America, 2018
Joshua Gorham   +2 more
exaly  

Home - About - Disclaimer - Privacy